AI Analysis AI Analysis of BEAM AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BEAM to Watchlist?
Some Reasons Why To Add BEAM:
  • +107.2% price growth over the last year
  • Low bankruptcy risk (Altman Z-Score: 5.93)
  • Bullish trend confirmed on both short and long timeframes
PDF

Beam Therapeutics Inc. stock price ended at $34.81 on Friday, after gaining 2.59%
(Updated on Jun 26, 2026)

Buy or Hold candidate since Jun 15, 2026 Gain 11.86%

The Beam Therapeutics Inc. stock price gained 2.59% on the last trading day (Friday, 26th Jun 2026), rising from $33.93 to $34.81. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 7.96% from a day low at $33.30 to a day high of $35.95. The price has risen in 7 of the last 10 days and is up by 18.36% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 5 million shares were bought and sold for approximately $166.68 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $35.96 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 22.91% during the next 3 months and, with a 90% probability hold a price between $35.02 and $44.20 at the end of this 3-month period.

BEAM Signals & Forecast

The Beam Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $34.00 and $30.87. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 22, 2026, and so far it has fallen -2.03%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Beam Therapeutics Inc. stock

Beam Therapeutics Inc. finds support from accumulated volume at $33.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.65 between high and low, or 7.96%. For the last week, the stock has had daily average volatility of 8.01%.

Our recommended stop-loss: $33.33 (-4.25%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (BEAM) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Beam Therapeutics Inc. to open at $34.69, and during the day (based on 14 day Average True Range), to move between $33.63 and $35.99, which gives a possible trading interval of +/-$2.35 (+/-6.99%) up or down from last closing price. If Beam Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 6.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $35.53 (2.07%) than the support at $33.20 (4.63%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Beam Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Beam Therapeutics Inc. stock to perform well in the short-term.

Current score: 3.767 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $34.69 ( 0.354%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BEAM Performance

Trading levels for BEAM

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 37.34 7.26%
R2 36.32 4.35%
R1 35.70 2.55%
Price 34.81
S1 33.67 -3.26%
S2 33.05 -5.06%
S3 32.04 -7.97%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 35.53 2.07%
Price 34.81
S1 33.20 -4.63%
S2 32.84 -5.66%
S3 27.11 -22.12%

BEAM Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 22, 2014 Feb 04, 2014 Mar 03, 2014 $0.225 0%
2 Sep 19, 2013 Nov 04, 2013 Dec 02, 2013 $0.225 0%
3 Jul 31, 2013 Aug 12, 2013 Sep 03, 2013 $0.225 0%
4 Apr 24, 2013 May 06, 2013 Jun 03, 2013 $0.225 0%
5 Jan 28, 2013 Feb 04, 2013 Mar 01, 2013 $0.225 0%

FAQ

What is the symbol for Beam Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Beam Therapeutics Inc. is BEAM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Beam Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Beam Therapeutics Inc. stock to perform well in the short-term.

How to buy Beam Therapeutics Inc. Stock?
Beam Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Beam Therapeutics Inc. Stock.

What's the current price of Beam Therapeutics Inc. Stock?
As of the end of day on the Jun 26, 2026, the price of an Beam Therapeutics Inc. (BEAM) share was $34.81.

What is the 52-week high and low for Beam Therapeutics Inc. Stock?
The 52-week high for Beam Therapeutics Inc. Stock is $36.88 and the 52-week low is $15.60.

What is the market capitalization of Beam Therapeutics Inc. Stock?
As of the Jun 26, 2026, the market capitalization of Beam Therapeutics Inc. is 3.581B.

When is the next earnings date for Beam Therapeutics Inc.?
The upcoming earnings date for Beam Therapeutics Inc. is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT BEAM THERAPEUTICS INC.
Beam Therapeutics
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-...
GOLDEN STAR
Ticker Change Signal Date
NMRK
$15.02
1.66% Jun 24
X
XMAX
$8.34
5.40% Jun 24
JLL
$299.78
5.10% Jun 24
NESR
$25.07
12.64% Jun 23
TTEK
$28.04
4.35% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE